DRUG DISCOVERY COLLABORATION OPTION AGREEMENTDiscovery Collaboration Option Agreement • April 29th, 2019 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 29th, 2019 Company Industry JurisdictionTHIS DRUG DISCOVERY COLLABORATION OPTION AGREEMENT (the “Agreement”) is made effective as of October 1, 2014 (“Effective Date”) by and between Array BioPharma Inc., a Delaware corporation, having its principal offices located at 3200 Walnut, Boulder, CO 80301 (“Array”), and Mirati Therapeutics, Inc., a Delaware corporation, having a place of business at 9363 Towne Centre Drive, Suite 200, San Diego, CA 92121 (“Mirati”).